Literature DB >> 3531936

Ripening of the human cervix and induction of labor with intracervical purified porcine relaxin.

A H MacLennan, R C Green, P Grant, R Nicolson.   

Abstract

In a randomized double-blind placebo-controlled trial involving 71 patients, a viscous gel containing distilled water or 1 or 2 mg pure porcine relaxin was instilled in the cervical canal on the evening before the surgical induction of labor. Eleven of 48 patients receiving relaxin labored overnight, whereas only one of 23 patients went into labor. Only the 2-mg dose significantly improved the mean cervical score compared with the placebo treatment; the effect was greatest in primigravid patients with unripe cervixes. Intracervical application appeared to confer no benefit over vaginal application in effecting cervical ripening or inducing labor. Systemic absorption of the porcine relaxin after its intracervical application was confirmed by the measurement of immunoreactive relaxin in a homologous porcine relaxin radioimmunoassay. Thus, the cervical ripening effect of exogenous relaxin may be mediated either systemically or by direct action at the site of local application. This trial confirms the responsiveness of the human term cervix to exogenous relaxin and supports the suggestion that endogenous relaxin may play a similar role at term in facilitating cervical ripening and parturition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531936

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

Review 1.  Chemotherapeutic induction of labour. A rational approach.

Authors:  E M Xenakis; J M Piper
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 2.  Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis.

Authors:  Ekaterina Mishanina; Ewelina Rogozinska; Tej Thatthi; Rehan Uddin-Khan; Khalid S Khan; Catherine Meads
Journal:  CMAJ       Date:  2014-04-28       Impact factor: 8.262

3.  The kinetics of relaxin oxidation by hydrogen peroxide.

Authors:  T H Nguyen; J Burnier; W Meng
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

Review 4.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

5.  The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration.

Authors:  S A Chen; A J Perlman; N Spanski; C M Peterson; S W Sanders; R Jaffe; M Martin; T Yalcinkaya; R C Cefalo; N C Chescheir
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

Review 6.  Relaxin for cervical ripening and induction of labour.

Authors:  A J Kelly; J Kavanagh; J Thomas
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 7.  The role of ultrasound in diagnosis of the causes of low back pain: a review of the literature.

Authors:  Pedram Heidari; Farzin Farahbakhsh; Mohsen Rostami; Pardis Noormohammadpour; Ramin Kordi
Journal:  Asian J Sports Med       Date:  2015-01-19

8.  Recombinant human relaxin versus placebo for cervical ripening: a double-blind randomised trial in pregnant women scheduled for induction of labour.

Authors:  Gerson Weiss; Sam Teichman; Dennis Stewart; David Nader; Susan Wood; Peter Breining; Elaine Unemori
Journal:  BMC Pregnancy Childbirth       Date:  2016-09-05       Impact factor: 3.007

9.  Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.

Authors:  Misaki Fue; Yasuhiro Miki; Kiyoshi Takagi; Chiaki Hashimoto; Nobuo Yaegashi; Takashi Suzuki; Kiyoshi Ito
Journal:  Int J Mol Sci       Date:  2018-08-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.